Sort
21,281 grants matching “influenza”
Vaccine and Treatment Evaluation Units: Protocol Development and Implementation for a Phase I Vaccine Trial for Influenza
$705,509Emmanuel Walter · Duke University · N01 · FY2019 · AI
Cincinnati Children's Hospital Medical Center Vaccine and Treatment Evaluation Units (UM1 Clinical Trial Required)
$705,487Robert Wilson Frenck · Cincinnati Childrens Hosp Med Ctr · UM1 · FY2023 · AI
Protective functions of influenza-specific lung-resident memory B cells
$705,329Troy D Randall · University Of Alabama At Birmingham · R01 · FY2021 · AI
Protective functions of influenza-specific lung-resident memory B cells
$705,329Troy D Randall · University Of Alabama At Birmingham · R01 · FY2025 · AI
Protective functions of influenza-specific lung-resident memory B cells
$705,329Troy D Randall · University Of Alabama At Birmingham · R01 · FY2020 · AI
Protective functions of influenza-specific lung-resident memory B cells
$705,329Troy D Randall · University Of Alabama At Birmingham · R01 · FY2023 · AI
Protective functions of influenza-specific lung-resident memory B cells
$705,329Troy D Randall · University Of Alabama At Birmingham · R01 · FY2024 · AI
Immunomodulation for Heart Allograft Tolerance
$705,227Richard N Pierson · University Of Maryland Baltimore · U01 · FY2014 · AI
Chlamydial Vaccine Testing in Mice and Guinea Pigs
$705,162Nilu Goonetilleke · Univ Of North Carolina Chapel Hill · U19 · FY2022 · AI
Dynamics of Influenza Transmission in Nicaraguan Households
$705,095Aubree L Gordon · University Of Michigan At Ann Arbor · R01 · FY2019 · AI
Prdm3/16 Regulate Chromatin Accessibility to Determine Alveolar Maturation
$705,023Jeffrey A Whitsett · Cincinnati Childrens Hosp Med Ctr · R01 · FY2025 · HL
Prdm3/16 Regulate Chromatin Accessibility to Determine Alveolar Maturation
$705,023Jeffrey A Whitsett · Cincinnati Childrens Hosp Med Ctr · R01 · FY2023 · HL
Prdm3/16 Regulate Chromatin Accessibility to Determine Alveolar Maturation
$705,023Jeffrey A Whitsett · Cincinnati Childrens Hosp Med Ctr · R01 · FY2022 · HL
Core B: Data Management and Analysis
$704,936Steven H. Kleinstein · Yale University · U19 · FY2019 · AI
Cell Based Immunomodulation to Suppress Lung Inflammation and Promote Repair
$704,795Ravi K Ghanta · Baylor College Of Medicine · R01 · FY2024 · HL
Effects of aging on primary and secondary vaccine responses in a 15-year longitudinal cohort
$704,782Scott Dexter Boyd · Stanford University · R01 · FY2021 · AI
PERSISTENCE OF IMMUNE RESPONSES TO THE RECOMBINANT ZOSTER VACCINE IN IMMUNE COMPROMISED HOSTS WITH END-STAGE RENAL DISEASE WITH AND WITHOUT KIDNEY TRANSPLANTATION
$704,735Adriana Weinberg · University Of Colorado Denver · U01 · FY2024 · AI
T5000 Diagnostic System in Ferret Model of Influenza
$704,636Frederick T Koster · Lovelace Biomedical & Environmental Research Institute · U01 · FY2007 · AI
Viral respiratory infections in a tracheostomy cohort: Microbiome-host interplay
$704,595Jonathan M Mansbach · Boston Children'S Hospital · R01 · FY2025 · AI
Small molecule inhibitory leads against influenza RdRp
$704,283Thomas Roy Webb · Sri International · R01 · FY2014 · AI
Linking SARS-CoV-2 Aerosol Viability and Environmental Factors in Healthcare Settings
$704,133Kerry Kelly · University Of Utah · R01 · FY2023 · AI
Role of Uncharacterized Genes in High Pathogenic Human Coronavirus Infection
$704,107Ralph S Baric · Univ Of North Carolina Chapel Hill · U19 · FY2016 · AI
Inflammation and Therapy for Respiratory Virus Infection
$704,016Helene Rosenberg · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
HMGB1-mediated host response to chronic bacterial infection
$704,003Steven D Goodman · Research Inst Nationwide Children'S Hosp · R01 · FY2024 · AI
Development of a Universal Influenza Vaccine Against Influenza A and B Viruses
$703,942Harvinder Singh Gill · Texas Tech University · R01 · FY2020 · AI